Tectonic Therapeutic, Inc.(TECX) - 2025 Q3 - Quarterly Results

Exhibit 99.1 Tectonic Therapeutic Announces Third Quarter 2025 Financial Results and Recent Business Highlights WATERTOWN, Mass., November 6, 2025 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) ("Tectonic"), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced financial results for the third quarter ended September 30, 2025, and provided an overv ...